Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy
This study has been completed.
Sponsor:
University of Virginia
Information provided by:
University of Virginia
ClinicalTrials.gov Identifier:
NCT00600158
First received: January 11, 2008
Last updated: January 23, 2008
Last verified: January 2008
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Epidural local anesthetics are the gold standard for shortening duration of bowel dysfunction after bowel surgery. Previous studies suggest that their effect may be in part a result of actions of the local anesthetic outside the epidural space. If local anesthetics could be administered intravenously instead, this might be a safer, easier and less expensive approach. Therefore, this trial will compare the effect on bowel function recovery of intravenous local anesthetics with those administered epidurally.
| Condition | Intervention | Phase |
|---|---|---|
|
Postoperative Ileus |
Drug: bupivacaine with hydromorphone Drug: lidocaine |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effects of Intravenous Local Anesthetic on Bowel Function After Colectomy |
Resource links provided by NLM:
MedlinePlus related topics:
Bowel Movement
Drug Information available for:
Hydromorphone hydrochloride
Lidocaine hydrochloride
Lidocaine
Hydromorphone
Bupivacaine hydrochloride
Bupivacaine
U.S. FDA Resources
Further study details as provided by University of Virginia:
Primary Outcome Measures:
- time from end of surgery to first sign of bowel function (stool or flatus) [ Time Frame: follow-up after surgery ] [ Designated as safety issue: No ]
Secondary Outcome Measures:
- Postoperative pain and opiate consumption [ Time Frame: post-surgery follow-up ] [ Designated as safety issue: No ]
- postoperative nausea and antiemetic use [ Time Frame: post-surgery follow-up ] [ Designated as safety issue: Yes ]
- duration of hospital stay [ Time Frame: post-surgery follow-up ] [ Designated as safety issue: No ]
| Enrollment: | 45 |
| Study Start Date: | April 2005 |
| Study Completion Date: | July 2006 |
| Primary Completion Date: | July 2006 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 2
lidocaine intravenously
|
Drug: lidocaine
lidocaine 2 mg/min intravenously (or 3 mg/kg in patients > 70 kg)
|
|
Active Comparator: 1
epidural local anesthetic
|
Drug: bupivacaine with hydromorphone
bupivacaine 0.125% with hydromorphone 6 mcg/ml epidurally at 10 ml/h
|
Show Detailed Description
Eligibility| Ages Eligible for Study: | 18 Years to 75 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Informed consent
- Scheduled for colon tumor resection.
- American Society of Anesthesiologists (ASA) physical classification classes I, II, and III.
Exclusion Criteria:
- Age <18 or >75 years
- Allergy to local anesthetics
- Severe cardiovascular disease (myocardial infarction within 6 months, profoundly decreased left ventricular function (ejection fraction <40%), or high-grade arrhythmias) or liver disease (known AST or ALT or bilirubin >2.5 times the upper limit of normal)
- Systemic corticosteroid use
- Chronic use of opiates
- Unwillingness or contraindication to epidural analgesia.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00600158
Locations
| United States, Virginia | |
| University of Virginia | |
| Charlottesville, Virginia, United States, 22908 | |
Sponsors and Collaborators
University of Virginia
Investigators
| Principal Investigator: | Marcel E Durieux, MD PhD | University of Virginia |
More Information
No publications provided by University of Virginia
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Marcel E. Durieux, MD PhD, Professor of Anesthesiology, University of Virginia |
| ClinicalTrials.gov Identifier: | NCT00600158 History of Changes |
| Other Study ID Numbers: | MED001 |
| Study First Received: | January 11, 2008 |
| Last Updated: | January 23, 2008 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of Virginia:
|
colectomy |
Additional relevant MeSH terms:
|
Ileus Intestinal Obstruction Intestinal Diseases Gastrointestinal Diseases Digestive System Diseases Anesthetics, Local Bupivacaine Lidocaine Anesthetics Hydromorphone Central Nervous System Depressants |
Physiological Effects of Drugs Pharmacologic Actions Sensory System Agents Peripheral Nervous System Agents Central Nervous System Agents Therapeutic Uses Analgesics, Opioid Analgesics Narcotics Anti-Arrhythmia Agents Cardiovascular Agents |
ClinicalTrials.gov processed this record on June 17, 2013